Paper Details 
Original Abstract of the Article :
<b><i>Objective:</i></b> To determine the prevalence of sexual dysfunction in female patients with schizophr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.4088/PCC.20m02835

データ提供:米国国立医学図書館(NLM)

Sexual Side Effects in Schizophrenia: Navigating the Desert of Medication

Schizophrenia, a complex mental health disorder, can significantly impact an individual's life. The use of antipsychotic medications is often essential for managing symptoms, but these medications can sometimes have unintended side effects, including sexual dysfunction. This study explores the prevalence of sexual side effects in female patients with schizophrenia receiving olanzapine or risperidone, highlighting the importance of understanding and addressing these potential challenges.

Finding a Balance in Medication Management

This study delves into the prevalence of sexual dysfunction in female patients with schizophrenia receiving olanzapine or risperidone. The research underscores the importance of open communication between patients and healthcare providers to address these concerns and find effective solutions.

Improving Quality of Life in the Desert of Mental Health

The study's findings emphasize the importance of considering the holistic needs of patients with schizophrenia, including their sexual health. This research highlights the need for individualized treatment plans that address both mental and physical well-being, ensuring a better quality of life.

Dr.Camel's Conclusion

This study explores the prevalence of sexual side effects in female patients with schizophrenia receiving antipsychotic medications. The research emphasizes the need for open communication and individualized treatment approaches to address these concerns and improve the quality of life for those living with schizophrenia.

Date :
  1. Date Completed 2021-10-15
  2. Date Revised 2021-10-15
Further Info :

Pubmed ID

34297487

DOI: Digital Object Identifier

10.4088/PCC.20m02835

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.